GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » Equity-to-Asset

Eurofins Scientific SE (Eurofins Scientific SE) Equity-to-Asset : 0.47 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Eurofins Scientific SE's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $5,537 Mil. Eurofins Scientific SE's Total Assets for the quarter that ended in Dec. 2023 was $11,874 Mil. Therefore, Eurofins Scientific SE's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.47.

The historical rank and industry rank for Eurofins Scientific SE's Equity-to-Asset or its related term are showing as below:

ERFSF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26   Med: 0.41   Max: 0.5
Current: 0.47

During the past 13 years, the highest Equity to Asset Ratio of Eurofins Scientific SE was 0.50. The lowest was 0.26. And the median was 0.41.

ERFSF's Equity-to-Asset is ranked worse than
65.27% of 239 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs ERFSF: 0.47

Eurofins Scientific SE Equity-to-Asset Historical Data

The historical data trend for Eurofins Scientific SE's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Equity-to-Asset Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.43 0.50 0.47 0.47

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.46 0.47 0.49 0.47

Competitive Comparison of Eurofins Scientific SE's Equity-to-Asset

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Equity-to-Asset falls into.



Eurofins Scientific SE Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Eurofins Scientific SE's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=5537.077/11874.155
=0.47

Eurofins Scientific SE's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=5537.077/11874.155
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins Scientific SE  (OTCPK:ERFSF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Eurofins Scientific SE Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.